Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Padres Rumors

Previewing Upcoming Opt-Out Decisions And Player Options

By | at

With the offseason approaching, so is the time for players and teams to decide upon any 2023 options in their contracts. MLBTR has taken a look through various option decisions in recent weeks: first with players whose deals contain vesting provisions, then a respective look at the team options in both the American and National Leagues.

Today, we’ll turn our attention to the players’ side. A number of players could hit free agency this winter either by triggering an opt-out clause in their current deal or bypassing a player option for the 2023 campaign. We’ll take a run through those decisions, many of which will have implications at the very top of the free agent market.

Note: All stats referenced are through play Sunday

Elite Potential Free Agents

  • Nolan Arenado, Cardinals 3B (can opt out of final five years and $144MM)

Arenado was already on a Hall of Fame trajectory before 2022, but he’s bolstering his case with the best season of his career. Through 500 plate appearances, he owns a .306/.370/.567 line with 27 home runs. He’s had seasons with that kind of slash line in years past, but they came with the caveat that he’d played half his games at Coors Field. That’s no longer a factor, and it’s easily his best offensive output once one adjusts for the ballpark. Arenado’s 162 wRC+ is the fourth-best mark among qualified hitters.

That kind of offensive production alone would get him in the MVP discussion, but Arenado’s obviously valuable for far more than his bat. One of the best defensive third basemen in MLB history, he’s continued to post elite marks with the glove even as he’s entered his 30s. Arenado is among the top handful of players in the game. While walking away from $144MM wouldn’t be an easy decision, it’d seem the prudent one from a strict financial perspective. Freddie Freeman received six years and $162MM from the Dodgers (albeit with deferrals that reduced the net present value closer to the $148MM range) headed into his age-32 season. Freeman was coming off a 135 wRC+ platform showing, and he plays a less valuable position. Arenado and his camp could make a strong argument the Freeman contract should represent his floor, and it’s not outlandish to seek a six-year deal at the $35MM annual range Anthony Rendon received from the Angels (which would bring the guarantee to $210MM).

On paper, Arenado’s opt-out decision looks like a slam dunk. There’s at least some amount of uncertainty, though, as he forewent an opt-out opportunity last offseason and told Derrick Goold of the Post-Dispatch it was “always the plan” to remain in St. Louis long term. Passing on free agency coming off a .255/.312/.494 showing in 2021 is a lot easier than doing so after a career-best year that should make him an MVP finalist. Maybe he’s comfortable enough with the Cardinals he’ll return, but he’d probably be leaving a lot of money on the table to do so. At the very least, he looks to have a case for a renegotiation of his contract with the Cards, which is slated to pay him just $15MM in the final season (2027).

  • Carlos Correa, Twins SS (can opt out of final two years and $70.2MM this offseason; deal also contains post-2023 opt-out if Correa opts in this winter)

Regarded by many (MLBTR included) as the top free agent in last winter’s class, Correa reportedly turned down at least one ten-year offer early in the offseason in search of a guarantee that rivaled the $341MM Francisco Lindor had received from the Mets last April. That proposal seemingly never came, and Correa reversed course in Spring Training. He signed a shocking three-year deal with the Twins that guaranteed him the largest annual salary ($35.1MM) for a free agent position player and afforded the opportunity to retest the market in either of the next two offseasons via opt-out.

Conventional wisdom was that Correa was sure to trigger his first opt-out and make another run at a long-term deal in a winter unaffected by a lockout. That still seems likely, although he hasn’t resoundingly made the case for teams to be more willing to approach the Lindor range that they had been. He’s having a similar offensive season as he did during his final year with the Astros. After posting a .279/.366/.485 showing his last year in Houston, Correa is hitting .276/.355/.439 over 440 plate appearances with Minnesota. His raw power production is down, but that’s not quite as alarming when considering the leaguewide slugging percentage has dropped from .411 to .395. Perhaps of greater concern is that the elite defensive marks that garnered Correa a Gold Glove last season are unanimously down, ranging anywhere from below-average (-2 Outs Above Average) to solid (+4 Defensive Runs Saved, +1 Ultimate Zone Rating).

There’s no question Correa’s an excellent player having a very good season. Yet he’s not likely to wind up a top five finisher in MVP balloting as he did in 2021. He’d top a $200MM guarantee on the open market, but he’s unlikely to reach the kind of money he anticipated last offseason. Could he return to Minnesota (where he’s by all accounts very happy) for one more year and look to trigger his post-2023 opt-out after hopefully putting up MVP-caliber numbers? That feels unlikely, but he’s already bet on himself once and would only be entering his age-29 season if he put off opting out for a year.

Bogaerts has been the Red Sox’s everyday shortstop since 2014, but his time in Boston could be nearing its end. He and the club didn’t make progress in extension talks this spring, and he’s a lock to opt out and top $60MM on the open market barring a catastrophic injury. One of the game’s top offensive shortstops, Bogaerts is amidst another strong season. He carries a .303/.372/.448 line through 508 plate appearances. His slugging output is below where it was from 2018-21, but he consistently gets on base and has a strong pre-2022 track record from a power perspective.

One can quibble about certain aspects of Boagerts’ profile. In addition to this year’s slugging dip, he’s traditionally rated as a below-average defender. Even with generally solid defensive metrics this season, clubs will probably have some question whether he’ll eventually need to move to second or third base. Those are nitpicks for whether Bogaerts would be a worthwhile investment in the $180MM – $200MM range, though. A 30-year-old shortstop with an elite durability track record and a .299/.370/.478 line since the start of 2020, he’s certainly going to shatter $60MM even if the market takes a relatively pessimistic view of his long-term projection.

  • Jacob deGrom, Mets RHP (can opt of final year and $33.5MM this offseason)

There’s no suspense with this one, as deGrom has publicly maintained his plan to opt out for months. That’s in spite of elbow/shoulder injuries that kept him from throwing a major league pitch between July 2021 and this August. With only one guaranteed year remaining on his deal (plus a 2024 club option that’d go into effect if he doesn’t opt out this winter), that’s been a pretty easy call. To the extent there may have been any lingering doubts, deGrom has silenced them with his first five starts since returning from the injured list. He’s looked like his vintage self, averaging 99.3 MPH on his fastball while posting a laughable 46:2 strikeout-to-walk ratio through 29 1/3 innings. On an inning-for-inning basis, he’s the best starting pitcher on the planet.

deGrom’s free agent case will be fascinating. Even if he finishes the season healthy, he’ll have gone three consecutive years without topping 15 starts or 100 innings (although he’s obviously not at fault for the shortened 2020 schedule). What kind of volume a signing team can expect is an open question, particularly as he enters his age-35 season. Yet the upside of a healthy deGrom is through the roof. He’ll receive a multi-year deal that beats the $33.5MM remaining on his current contract. Can he top teammate Max Scherzer’s $43.333MM AAV over a three or even four-year term? Time will tell.

While we’re on the topic of upper-echelon starting pitchers who are basically certain to opt out, let’s turn to Verlander. The future Hall of Famer triggered a $25MM option for next season by throwing 130 innings, but that’s largely a moot point. Verlander told Ken Rosenthal of the Athletic last week he was likely to opt out if things went as planned down the stretch. It’d have been surprising if he were even considering exercising the option.

Verlander has returned from 2020 Tommy John surgery to lead the major leagues with a 1.84 ERA. He’s striking out 26.5% of opponents and has a strong argument for a third career Cy Young award. He’s also a proven playoff performer and a prototypical ace who eats about as many innings as anyone else in the game. Even heading into his age-40 season, Verlander can try to beat the Scherzer AAV on a multi-year contract.

Verlander did injure his calf in his most recent start, resulting in a placement on the injured list just this afternoon. The Astros announced that an MRI of his calf revealed “fascial disruption, but no muscle fiber disruption” — an extremely specific diagnosis but one that both Verlander and GM James Click touted as good news. Click expressed hope the injury will be short-term, and Verlander suggested that had he sustained damage to the muscle fibers themselves, he’d likely have missed the remainder of the regular season and perhaps part of the postseason.

The manner to which Verlander rebounds will obviously be key in his opt-out scenario, but if he misses only a couple weeks’ time and returns strong for his final regular-season and postseason starts, this opt-out is an easy call.

We’ll wrap up the trifecta with Rodón, who’s also going to have an easy decision, barring injury. While there was some trepidation about Rodón’s breakout 2021 season — both due to his inconsistent track record before last season and some shoulder soreness and a velocity drop last August — he’s doubled down and looks to have cemented himself among the game’s top ten starters. Rodón has avoided the injured list thus far, and he’s striking out 32.1% of opponents while posting a 2.81 ERA through 25 starts. By topping 110 innings, he earned the right to opt out after this season.

Heading into his age-30 campaign, he should land the nine-figure deal that eluded him last offseason. Between his youth and last two years of production, Rodón has an argument for the largest guarantee of any free agent starter. He won’t get paid at the deGrom or Verlander level on an annual basis, but he could push for six years and look to top $150MM.

Quality Regulars Likely To Opt Out

Rizzo’s market last offseason seemed a bit underwhelming. The veteran first baseman was coming off two fine but unspectacular seasons, and it looked as if his best days might be behind him with his mid-30s approaching. Rizzo still made plenty of contact and hit the ball hard, but he’d gotten quite pull-oriented and had rough ball-in-play results against an increasing number of defensive shifts. He signed a two-year deal with the Yankees that paid him matching $16MM salaries and allowed him to opt out after this season.

That now looks like an easy call, as Rizzo has bounced back with a year more reminiscent of his peak days with the Cubs. He carries a .223/.337/.480 line and is going to top 30 homers for the first time since 2017. He’s still getting dismal results on balls in play and doesn’t have a particularly impressive batting average, but even that looks as if might turn around next year. It’s widely expected MLB will institute limits on shifting next spring. Few players would stand to benefit more than Rizzo, who’s facing a shift on a whopping 83.5% of his plate appearances according to Statcast. His age and lack of defensive versatility will limit the length of any deal, but he’ll probably beat the $16MM salary over at least a two-year term, even if the Yankees tag him with a qualifying offer.

The Padres’ signing Profar to a three-year, $21MM deal that allowed him multiple opt-out chances was one of the more eyebrow-raising moves of the 2020-21 offseason. The switch-hitter was coming off a solid 2020 campaign, but that shortened schedule was the first in which he’d posted above-average production. It looked like a misstep when he struggled last year and unsurprisingly forewent his first opt-out clause, but Profar has rewarded the organization’s faith with a career-best showing in 2022.

Through 530 plate appearances, he’s hitting .241/.339/.387 with 12 homers. He’s walking at a robust 12.3% clip while only going down on strikes 15.1% of the time. He looks like a solid regular, and headed into his age-30 season, Profar’s a candidate for another multi-year deal this time around. After major throwing issues as an infielder early in his career, he’s played exclusively left field this year. Profar isn’t a prototypical corner outfield masher, but his plate discipline and bat-to-ball skills should allow him to top the guaranteed money remaining on his current deal.

Starting Pitchers With High Buyouts

Walker signed a $20MM guarantee with the Mets over the 2020-21 offseason. The deal was front-loaded but came with a $6MM player option or a $3MM buyout for 2023. Adding a player option allowed the Mets to soften the contract’s luxury tax hit. Because player options are treated as guaranteed money, it technically qualified as a three-year, $20MM deal with a $6.67MM average annual value for CBT purposes. Yet the $3MM gap between the option value and the buyout meant Walker was a virtual lock to opt out, barring injury that made him unable to pitch next season. The Associated Press reports the option has various escalators that could push its value as high as $8.5MM if Walker throws 175 innings this year, but even that figure is modest enough he’s going to decline.

Walker should opt out in search of a multi-year deal, as he’s been a valuable mid-rotation arm for New York. Over 117 1/3 frames, he owns a 3.38 ERA despite a modest 18.3% strikeout rate. His blend of plus control and solid ground-ball rates makes him a candidate for a three-year pact as he heads into his age-30 season. The Mets will have an interesting decision on whether to tag him with a qualifying offer.

Like Walker, Odorizzi signed late in the 2020-21 offseason on a deal that locked in the first two seasons and gave the player a third-year option. Odorizzi’s contract with the Astros was similarly structured to facilitate a third-year buyout while diminishing the AAV for luxury tax purposes, although he’s deciding on a bit more money. The option was initially valued at $6.5MM with a $3.25MM buyout, but the Associated Press provided a breakdown of various escalators. The option value would jump by $2MM apiece if Odorizzi reached 20, 25 and 30 appearances between 2021-22 in which he either started the game or worked four-plus innings of relief. The buyout value would spike by $1MM apiece for hitting each of those thresholds.

Odorizzi has already made 41 such appearances over the past two years, so he’s long since maxed out both thresholds. He’ll therefore be deciding between a $12.5MM option to return to the Braves or taking a $6.25MM buyout and heading to free agency. With only a $6.25MM difference between the option value and the buyout, Odorizzi looks like a borderline opt-out case. He owns a 3.90 ERA across 85 1/3 innings this season, although his 18.3% strikeout rate is a few points below league average. He’ll be 33 by next Opening Day, and he didn’t find as robust interest as most expected he would during his last trip through free agency. He’s a quality strike-thrower and a perfectly fine back-of-the-rotation starter, but it’s now been three years since he’s missed bats at an above-average rate, and he was traded this summer in a one-for-one swap for an underperforming reliever (Will Smith).

Easy Calls To Return

  • Chris Sale, Red Sox LHP (can opt out of final two years and $55MM)

Sale has the right to pass on the final two years of his extension with the Red Sox this winter, but he certainly won’t do so. He’s made just 11 starts over the past three seasons due to various injuries, including a 2020 Tommy John surgery and a trio of fractures (rib, finger and wrist) this year. Sale has still flashed mid-rotation or better upside in the limited time he’s been on the field, but there’s too much uncertainty with his health to land anywhere near $55MM were he to test the market.

  • Eric Hosmer, Red Sox 1B (can opt out of final three years and $39MM)

Hosmer’s opt-in decision is a no-brainer. Since signing a $144MM contract with the Padres heading into 2018, he’s posted a league average .264/.325/.409 slash line. Paired with his lack of defensive versatility and mixed reviews on his glovework (public metrics have never been as fond of Hosmer as his four Gold Gloves would suggest), he’d probably be limited to one-year offers were he a free agent. The Padres will remain on the hook for virtually all of the money, as they agreed to pay down Hosmer’s deal to the league minimum salary to facilitate his trade to the Red Sox.

  • Jorge Soler, Marlins LF (can opt out of final two years and $24MM; deal also contains post-2023 opt-out if Soler opts in this year)

Soler parlayed a big second half and huge batted ball metrics into a three-year deal with Miami last offseason. His massive raw power hasn’t translated into especially strong results since he’s become a Marlin, however. He’s been a below-average hitter, and it’s now been three years since he was a middle-of-the-order caliber player over a full season. Paired with a limited defensive profile that keeps him in the corner outfield or at designated hitter, he’s been right around replacement level this season. He’s not opting out this year, but a big showing in 2023 could allow him to reconsider the possibility next winter.

  • AJ Pollock, White Sox LF ($11MM option, $5MM buyout)

The White Sox acquired Pollock just before the start of the season, sending Craig Kimbrel to the Dodgers in a surprising one-for-one swap. The hope was that they’d addressed a notable hole in the corner outfield, but Pollock’s production has cratered in Chicago. Just a season removed from a .297/.355/.536 showing in L.A., he’s stumbled to a .237/.284/.363 line through 401 plate appearances with the ChiSox. Even with a fairly modest $6MM gap between the option’s present value and the buyout, Pollock is likely to bypass a trip to free agency after a replacement-level platform season.

The present $11MM option value isn’t fixed, as Pollock’s contract contains escalators that could boost it a bit further. Originally set at $10MM, he’d lock in an extra $1MM for hitting each of 400, 450, 500, 550 and 600 plate appearances this season. He’s already surpassed 400 trips, and the 450 mark is well within range with 34 games remaining. Consistent playing time down the stretch would allow him to reach 500 plate appearances as well, although it’s hard to envision him getting to 550. The most likely outcome is that the option price ends up at $12MM, but anywhere between $11-13MM is viable.

Schoop signed a two-year, $15MM extension amidst a productive 2021 season in Detroit. While a defensible enough decision for the Tigers at the time, that hasn’t panned out. The veteran second baseman has a .235 on-base percentage that’s easily the worst in the majors among players with 400+ plate appearances. He’s posted otherworldly defensive marks this season and could well collect a Gold Glove, but the complete lack of production at the dish should make him a lock to exercise his option.

Blackmon exercised a 2022 option last season, and he went on the record at the time as saying he’d trigger the 2023 provision as well. There’s no intrigue as to his decision — he’ll be back in Colorado next year — the only question is how much he’ll make. The ’23 option came with a $10MM base value, but ESPN reported it’d escalate by $500K apiece if Blackmon reached 400, 425, 450, 475, 500, and 525 plate appearances in 2022. It’d jump another $1MM apiece at 550 and 575 trips.

The veteran outfielder enters play Tuesday with 490 plate appearances, so he’s already pushed the value to $12MM. Barring injury, he’s a lock to hit at least the 525 PA mark, and he’s quite likely to get all the way to 575. Colorado has 33 games remaining, and Blackmon is only 85 plate appearances (2.76 per game) from maxing out the plate appearance threshold at $15MM. The deal also contained escalators based on MVP finishes which Blackmon will not hit.

Relievers

  • Nick Martinez, Padres RHP (can opt out of final three years and $19.5MM this offseason, $1.5MM buyout; deal also contains opt-out chances after 2023 and 2024 if Martinez opts in)

Martinez signed a four-year, $25.5MM guarantee with San Diego this past winter. That deal contained opt-out chances after each of the first three seasons for the former NPB hurler, but it seems unlikely Martinez will take his first opportunity to return to the open market. He has a strong 3.02 ERA over 92 1/3 innings during his return season in the big leagues, but he’s worked as a swingman for a San Diego team that has quite a bit of rotation depth. Martinez has excelled as a reliever, pitching to a 1.35 ERA while holding opponents to a .208/.258/.295 line in 40 innings. That’s come with a modest 21.5% strikeout rate, though, and he doesn’t brandish the power arsenal teams tend to prioritize late in games.

Entering his age-32 season, Martinez probably wouldn’t find a better deal that the opt-out laden three years and $18MM (after factoring in the buyout price) he’d be bypassing to return to the open market. The Friars have to be happy with their investment considering his excellence out of the bullpen, but the surprisingly strong deal they gave him in the first place makes it hard to see him doing much better elsewhere even on the heels of a quality first season.

Detroit signed the ever-reliable Chafin late last offseason, and they’ve been rewarded with another excellent year. Through 43 1/3 innings, he’s posted a 2.91 ERA while striking out more than 30% of opponents with an excellent 52.3% ground-ball rate. The market probably undervalued Chafin last winter; it’d be hard to do so again after another very good season. In a vacuum, declining the option and topping $6.5MM in free agency seems likely.

That said, the Tigers decision to not trade Chafin at this summer’s deadline was tied to a belief he could stick around. Evan Petzold of the Detroit Free-Press reported shortly before the deadline that Detroit’s proximity to Chafin’s Ohio home could lead him to return in 2023 if he weren’t moved before August 2. That led to a disconnect in his trade value, with the Tigers confident they still possessed a year and a half of his services while other clubs viewed him as an impending free agent. From a strict financial perspective, opting out is the prudent call. Yet the family considerations Petzold noted would make the decision more complicated if Chafin’s priority isn’t simply to maximize his earnings.

San Diego added Suárez, who’d never previously pitched in the majors, on the heels of an excellent career closing in Japan. He had a nightmare outing on Opening Day where he dished out free passes to all three batters he faced, but he’s been quite effective since that point. Excluding his first appearance, Suárez owns a 2.36 ERA with a strong 29% strikeout rate in 34 1/3 innings. He’s still had spotty control, but he’s averaging north of 97 MPH on his fastball. He’d only need to beat $4MM on the open market, and something around that rate over a multi-year term feels attainable heading into his age-32 season. A rough final couple months could change the calculus, but Suárez seems likely to retest free agency at the moment.

Padres Promote Jose Castillo

By | at

The Padres announced this evening that reliever José Castillo has been called up from Triple-A El Paso. Starter Yu Darvish is going on paternity leave in a corresponding transaction. While the club hadn’t made an announcement at the time, Kevin Acee of the San Diego Union-Tribune reported last week that San Diego had added Castillo to the 40-man roster to keep him from opting out of his minor league contract.

Now that he’s back in the big leagues, the southpaw is nearing his first MLB appearance in three years. Castillo broke in with the Friars in 2018 and immediately impressed. Over 38 1/3 frames as a rookie, he worked to a 3.29 ERA with an elite 34.7% strikeout rate and an average 8% walk percentage. Castillo’s fastball sat in the 95 MPH range, and he held opposing left-handers to a pitiful .133/.220/.133 line in 50 plate appearances.

Castillo looked like a long-term bullpen piece, but his career has been thrown off track by a brutal series of injuries. He missed a good chunk of the 2019 campaign after suffering a flexor strain in his forearm. Castillo returned, made one appearance, then torn a ligament in his throwing hand. That ended his season, but it was far from the end of his injury troubles. The Venezuela native suffered a teres major strain in his shoulder in July 2020 and spent the entire shortened season on the IL. He tried to return last year, but he blew out in Spring Training and underwent Tommy John surgery in March.

In light of all the injuries, San Diego outrighted Castillo off the 40-man roster last offseason. They brought him back on a non-roster deal to give him another chance at getting back on track. Castillo finally returned to health in early May and reported to El Paso, and he’s picked up right where he’d left off in 2018 from a performance standpoint. Over 34 2/3 Triple-A frames, he owns a 2.08 ERA with a 32.6% strikeout rate, although his walk percentage has jumped to a somewhat alarming 10.1% clip. The free passes have shown up in a .359 on-base percentage allowed to lefty batters this season, but same-handed hitters are hitting only .227 and have collected a lone extra-base hit (a double) in 44 at-bats against him in Triple-A.

Castillo is still only 26 years old, and his upper minors dominance makes him an intriguing addition to the Friars bullpen for the stretch run. It’s certainly not out of the question he reestablishes himself as a key late-game option for manager Bob Melvin. Castillo collected big league service from 2019-21 while on the major league injured list, but he’s still set to finish this season with between three and four years of service time. He’ll be arbitration-eligible through at least 2025 as a result, making him a potential long-term option for San Diego if he again handles big league hitters. Regardless of how well he fares moving forward, Castillo can take no small amount of pride in working his way back to the highest level after such a horrific stretch of injury luck.

Fernando Tatis Jr. To Undergo Shoulder Surgery

By | at

Fernando Tatis Jr. announced this afternoon that he will undergo surgery on his left shoulder (relayed by Jeff Sanders of the San Diego Union-Tribune and Darnay Tripp of NBC 7 San Diego). The Padres star is already out for the rest of the 2022 season after MLB handed down an 80-game suspension this month once Tatis tested positive for the banned performance-enhancing drug Closetebol. The surgery, which will take place shortly, is not expected to sideline Tatis beyond the length of his suspension, relays via AJ Cassavell of MLB.com.

It’s a somewhat surprising development, as there was no previous indication that surgery was again under consideration. Tatis twice landed on the IL with shoulder issues last season, missing the minimal ten days in April and another couple of weeks in August. In both instances, he suffered the injury on basic baseball activities — his first occurring on a swing, his second sliding into a base. Both injuries initially seemed to have the potential for extended absences, but Tatis returned in relatively short order each time.

There was some speculation Tatis may need to go under the knife, but he declined to undergo surgery at the end of last season. His plans to play through any discomfort this year were twice dashed — first by an offseason fracture in his left wrist sustained in a motorcycle accident, then by the suspension. Tatis underwent wrist surgery this spring. Initially expected to return around June, his recovery nevertheless lingered into the late summer. He embarked on a minor league rehab assignment at the start of this month, but MLB announced the stunning news of his failed PED test after just four Double-A games.

That suspension will carry over into the start of next season. Tatis will miss the final 48 regular season games of the 2022 campaign, leaving him with 32 more games to serve after this regular season. Any lost postseason contests (should San Diego qualify) will also count against the tally, but Tatis would miss a month or more of the 2023 campaign if the Friars don’t go on an extended playoff run this year. With the lengthy absence already in play, it seems Tatis and the organization decided the time was right for him to correct the shoulder woes.

Padres To Use Closer Committee, Give Josh Hader “A Little Break” From Save Chances

By | at

Since being acquired by the Padres in a surprising deadline trade, Josh Hader’s San Diego tenure has gotten off to a rough start.  The All-Star has been scorched for six runs over his last three outings and 1 1/3 innings of work, and as a result, Hader has temporarily lost the closer’s job.  As Padres manager Bob Melvin told reporters (including The Athletic’s Dennis Lin), the team will deploy a committee for the ninth inning, while giving Hader “a little break” from save situations.

This obviously isn’t the outcome the Padres were hoping for when they gave up a significant prospect package to the Brewers on August 1, in addition to taking on the remainder of Hader’s $11MM salary for the 2022 season.  However, it is worth noting that we’re dealing with a very small sample size of 3 1/3 total innings for Hader in a Padres uniform.  In three of his five appearances, Hader has allowed two hits and a walk over 2 2/3 scoreless frames — but, in his other two outings, the Giants and Nationals each scored three runs off the right-hander.  The result is a 16.20 ERA for Hader since coming to San Diego.

These recent struggles also underline Hader’s dropoff in performance since the start of June.  Hader didn’t allow a single earned run over his first 19 appearances of the season, but over his last 19 2/3 innings, his ERA is a whopping 10.07, with three blown saves in 14 chances.  For comparison’s sake, Hader only blew three saves total during the 2020-21 seasons.

It is quite possible that Hader might regain his form once he gets a few more games under his belt in San Diego, and in this scenario, it might not be long before he is Melvin’s top choice at closer once again.  In the interim, the Padres could turn to any of Robert Suarez, Luis Garcia, Adrian Morejon, or Nick Martinez in save situations, depending on recent usage or specific situations.

Padres Designate Nomar Mazara For Assignment

By | at

The Padres announced that outfielder Nomar Mazara has been designated for assignment.  In the corresponding move, outfielder Jose Azocar was called up from Triple-A.

Mazara signed a minor league deal with San Diego during the offseason, reuniting the former top Rangers prospect with Padres president of baseball operations (and former Rangers front office member) A.J. Preller.  The Padres selected Mazara’s contract in early June, and he has hit .264/.316/.352 with two home runs over 171 plate appearances.

Brought up to add some left-handed depth to San Diego’s bench, Mazara has actually performed better (.777 OPS) in 25 PA against left-handed pitching than over 146 PA against right-handed pitching (.649 OPS).  The additions of Juan Soto and Josh Bell added a lot of extra balance to the Padres lineup and made Mazara a little redundant, especially considering that the Padres also have the left-handed hitting Trent Grisham and the switch-hitting Jurickson Profar in their first-choice outfield.

While Mazara’s numbers aren’t anything spectacular, they still represent an improvement over his last two seasons, when he hit .219/.285/.309 over 330 combined PA with the White Sox and Tigers in 2020-21.  This could be enough for Mazara to perhaps get a look on the DFA wire from a team in need of outfield depth, or another executive (like Preller) could have memories of Mazara’s potential as a highly-touted minor leaguer.

Injury Notes: Mahle, Meadows, Walker, Johnson

By and | at

The Twins are surely breathing a sigh of relief, announcing to reporters Thursday that an MRI revealed right-hander Tyler Mahle’s shoulder to be structurally sound. Mahle, acquired from the Reds in exchange for three prospects earlier this month, exited yesterday’s start after just 2 1/3 innings due to shoulder fatigue. That was of particular concern, given that he also missed time in July with what was termed by the Reds as a “minor'” shoulder strain. For the time being, there are no plans to place Mahle on the 15-day injured list, though it’s not yet clear whether his next start will be pushed back at all.

Mahle’s Wednesday start saw his fastball clocking in around four miles per hour shy of his typical 93.4 mph average, so there’s still some obvious concern, but the absence of a tear or any structural issues is about the best news for which the Twins could have hoped. In 14 1/3 innings as a Twin, Mahle has pitched to a 2.51 ERA with a 23.1% strikeout rate and a 7.7% walk rate. Mahle, Sonny Gray, Joe Ryan, Chris Archer and Dylan Bundy are in line to make the majority of the Twins’ starts down the stretch, though they’re expecting right-hander Bailey Ober back in September and just this week promoted prospect Simeon Woods Richardson from Double-A to Triple-A.

Some more injury scenarios of note from around the league…

  • As if things couldn’t get any worse for the Tigers, manager A.J. Hinch announced this week that outfielder Austin Meadows has once again been pulled from a rehab assignment (link via Chris McCosky of the Detroit News). Meadows first hit the injured list back in mid-May due to vertigo-like symptoms and returned a bit less than a month later. That return lasted only eight games, however, before he was placed on the Covid-related injured list. Just as Meadows was getting ready to head out on a rehab assignment, he was transferred to the 10-day injured list owing to the bizarre diagnosis of an Achilles strain in both legs. This now marks the second time that Meadows has had a rehab assignment for this injury halted. Hinch’s only update was that Meadows was headed to Detroit for reevaluation and that the Tigers still have hope he can return in 2022. It’s been a nightmare of a season for Meadows, who has been limited to just 147 plate appearances and seen his power disappear: .250/.347/.328.
  • Mets righty Taijuan Walker left his most recent start due to back spasms, with an MRI revealing a slight disc bulge in his lower back, reports Anthony DiComo of MLB.com. However, it’s possible he could make his next scheduled start on Sunday. Walker tells DiComo that he is “shocked” to be feeling so good so soon after experiencing “the worst pain I ever felt.” Although he’s feeling better, he still won’t take the mound on Sunday unless he’s feeling 100 percent, per DiComo. If he is indeed recovered, it would be a tremendous gift for the Mets, given the current pressures on their rotation. With Carlos Carrasco recently landing on the IL and the Mets having a doubleheader on Saturday, having to make it through Sunday without Walker would certainly be a challenge. How his back responds over the next few days will determine if the club can avoid that tricky scenario.
  • Padres reliever Pierce Johnson is heading out on a rehab assignment, tweets Kevin Acee of the San Diego Union-Tribune. Johnson had an excellent season for San Diego a year ago, throwing 58 2/3 innings with a 3.22 ERA and 31.6% strikeout rate. The Friars held a $3MM club option over Johnson’s services for this year, which they exercised based on that strong showing last season. Unfortunately, Johnson landed on the IL in April due to elbow tendinitis. He’s yet to return, meaning he’s only been able to get into six games this year. After a layoff of about four months, it seems he’s healthy enough to get back into game shape. Once he’s ready to return to the big league club, he should give the bullpen a boost for the final few weeks of the season.

Padres To Sign Brandon Kintzler To Minor League Deal

By | at

Right-handed pitcher Brandon Kintzler is set to sign a minor league deal with the Padres, reports Jesse Rogers of ESPN.

Kintzler, 38, appeared in 12 straight MLB seasons from 2010 to 2021, and will look to make it lucky 13 here in 2022. He began his big league career with the Brewers before going to the Twins, Nationals, Cubs, Marlins and Phillies. In 483 career games, he has a 3.50 ERA, largely due to his ground ball-inducing ways. His 16.8% career strikeout rate is below average, but he’s managed to get hitters to put the ball into the dirt on 56.4% of balls in play. He’s also avoided free passes, keeping walks down to a 6.5% rate.

He signed with the Phillies last year but endured a rough campaign. After registering a 2.68 ERA in 2019 and a 2.22 mark in 2020, it shot up to 6.37 last year. He still got strikeouts, walks and grounders at roughly his career rates, but his .369 batting average on balls in play was much worse than previous seasons. He also saw 29.2% of fly balls turn into homers, more than double his career rate. He was designated for assignment after the Phils made some acquisitions at the trade deadline, getting released in early August.

After now sitting on the sidelines for an entire year, Kintzler will gear back up with the Padres. The club has five relievers currently on the injured list, including four on the 60-day IL: Austin Adams, Pierce Johnson, Drew Pomeranz and Craig Stammen. Kintzler will presumably join the Triple-A El Paso Chihuahuas at some point and start to get into game shape, providing the Friars with some veteran bullpen depth.

Fernando Tatis Jr. Suspended 80 Games For Performance-Enhancing Drug Violation

By | at

Fernando Tatis Jr.’s 2022 season is over. In a stunning development, Major League Baseball announced Friday afternoon that the Padres star has tested positive for Clostebol, a banned performance-enhancing substance. He’s been suspended for 80 games without pay, effective immediately. Tatis, who confirmed he’s already dropped an appeal he’d initially filed, goes on the restricted list.

Tatis released a statement via the MLB Players Association (Twitter link):

“I have been informed by Major League Baseball that a test sample I submitted returned a positive result for Clostebol, a banned substance. It turns out that I inadvertently took a medication to treat ringworm that contained Clostebol. I should have used the resources available to me in order to ensure that no banned substances were in what I took. I failed to do so.

I want to apologize to (owner Peter Seidler), (president of baseball operations A.J. Preller), the entire Padres organization, my teammates, Major League Baseball, and fans everywhere for my mistake. I have no excuse for my error, and I would never do anything to cheat or disrespect this game I love. … I am completely devastated. There is nowhere else in the world I would rather be than on the field competing with my teammates. … I look forward to rejoining my teammates on the field in 2023.”

The Padres released a briefer statement of their own on the news:

“We were surprised and extremely disappointed to learn today that Fernando Tatis Jr. tested positive for a performance-enhancing substance in violation of Major League Baseball’s Joint Prevention and Treatment Program and subsequently received an 80-game suspension without pay. We fully support the Program and are hopeful that Fernando will learn from this experience.”

Preller confirmed to reporters (including Kevin Acee of the San Diego Union-Tribune and Dennis Lin of the Athletic) that the organization learned about the suspension this afternoon, around two hours before it was made public. The Padres baseball ops leader was forthright about his frustration, suggesting that “over the course of the last six or seven months, I think (trust has) been something that we haven’t really been able to have.” That’s presumably in reference to the motorcycle accident that fractured Tatis’ wrist. Preller continued, “I think we’re hoping that from the offseason to now, that there would be some maturity. And obviously with the news today, it’s more of a pattern and something we’ve got to dig a little bit more into. I’m sure he’s very disappointed, but at the end of the day, it’s one thing to say it. You have to start by showing it with your actions.”

Tatis will go the entire 2022 season without appearing in a major league game. (Bob Nightengale of USA Today tweets that he’ll also be barred from representing the Dominican Republic in next spring’s World Baseball Classic). The star shortstop sustained a fracture in his left wrist in an offseason motorcycle accident, an injury that was revealed when he reported to the team in Spring Training. He underwent surgery and was out of action for months. There was finally light at the end of the tunnel, with Tatis sent to Double-A on a rehab assignment last week. He’d played in four minor league games and was set to rejoin the big league club within a couple weeks. That’ll no longer be the case.

The Padres have 48 more games on the regular season schedule. That’ll leave him in position to miss as many as the first 32 games of the 2023 season as well, although Tatis’ suspension would be reduced for any playoff games he misses (if the Padres reach the postseason this year).

It’s a crushing blow to a San Diego team that enters play Friday night in possession of the National League’s final Wild Card spot. They’re just a game clear of the Brewers, setting the stage for a tightly contested pennant race. If they’re to get to the postseason, the Friars will have to do it without the elite midseason reinforcement on whom they’d been counting.

That’s not to say the Padres are doomed. They’ve been without the two-time Silver Slugger winner all season, and they’re nevertheless 12 games above .500 with a +40 run differential. The deadline blockbuster to add Juan Soto and Josh Bell looms larger than ever now. San Diego still has a fearsome middle of the order anchored by Soto, Bell and Manny Machado, while Jake Cronenworth and Jurickson Profar have each hit at above-average levels.

There’s no way to replace a player who owns a .292/.369/.596 slash line through his first three big league seasons, but the Padres are in as good a position as a team can reasonably be to weather Tatis’ absence. They’ve gotten strong play from Ha-Seong Kim at shortstop in his second MLB season. The former KBO star is hitting .247/.324/.371 through 392 plate appearances, exactly league average offense by measure of wRC+. Public metrics have pegged Kim as one of the sport’s top defensive shortstops, making him a more than adequate fill-in for the remainder of the season.

Perhaps the greater roster ramification is that San Diego now has little recourse to replace scuffling center fielder Trent Grisham. Tatis had been slated to play both shortstop and center field on his rehab assignment, and he may well have gotten more time in the outfield down the stretch. While Kim has held down shortstop effectively all year, Grisham owns a .195/.292/.357 line over 411 trips to the plate. He has continued on as the primary center fielder, although Wil Myers has gotten the nod the past three times the Friars have faced a left-handed opposing starter. Skipper Bob Melvin figures to stick with at least a soft platoon arrangement for the stretch run.

While the team will feel the strongest repercussions down the stretch this year, Tatis’ lack of availability in 2022 has to be alarming to the organization over the long term. He’s under contract for another 12 seasons beyond this one under the extension he signed in February 2021. That $340MM deal is the fourth-largest in MLB history, and there’s arguably no one more important to the franchise’s long-term future.

That deal is backloaded. Tatis’ forfeited salary during the suspension, while substantial, isn’t nearly as significant as it would have been had he tested positive a couple years from now. He’ll lose the remainder of this year’s $5MM salary (approximately $1.5MM) as well as around a month’s worth of next year’s $7MM salary. The extent of his salary forfeiture is dependent on how many games he loses next season, which is subject to how far into the playoffs the Friars get this year. He’s likely to miss around 20% of the schedule, which would translate to around $1.3MM in lost salary next year.

Jeff Passan of ESPN first reported that Tatis had failed a PED test and was facing a suspension.

Image courtesy of USA Today Sports.

Previewing Upcoming Club Option Decisions: National League

By | at

In the past two days, MLBTR has taken a look at how players with contractual options could impact the upcoming free agent class. We looked at players with vesting provisions on Tuesday before turning our attention to American League players under control via team options yesterday. Today, we’ll check in on their National League counterparts.

Braves

It has been strange year for Morton, who starred on last year’s World Series winner. He re-signed on a $20MM deal with a matching option for next season. Through 22 starts and 122 2/3 innings, the two-time All-Star has a slightly underwhelming 4.26 ERA. That’s largely attributable to a dreadful first couple months, however. He has an ERA of 3.55 or below in each of the past three months, carrying a cumulative 3.44 mark while holding opponents to a .198/.276/.369 line since June 1. Morton is still sitting in the mid-90’s with his fastball, striking batters out at a quality 27.3% clip and has ironed out his control after some uncharacteristic wildness through his first few starts. At first glance, a $20MM salary seems pricey for a pitcher entering his age-39 season with Morton’s overall numbers, but he’s not shown any signs of physical decline and has looked great lately. If he keeps at this pace for another two months, the Braves will probably welcome him back. That, of course, assumes Morton wants to continue playing. He’s hinted at retirement in years past and set fairly strict geographic limitations on his market during his latest trips to free agency.

Mets

The Mets acquired Vogelbach from the Pirates to add a left-handed platoon bat to what had been an underwhelming designated hitter mix. He’d hit .228/.338/.430 through 75 games in Pittsburgh and has raked at a .341/.473/.568 clip over his first couple weeks in Queens. For a negligible $1.5MM salary, keeping Vogelbach around feels like an easy call. He’s technically arbitration-eligible through 2024 regardless of whether the Mets exercise his option. The option price should be more affordable than whatever he’d receive through arbitration next offseason, so if the Mets surprisingly declined the option, they’d likely non-tender him entirely.

  • John Curtiss, RP ($775K option, arbitration-eligible through 2025)

There’s nothing new to report on Curtiss. He signed a big league deal just before Opening Day with the knowledge that he’d likely miss all of this season recovering from last August’s Tommy John surgery. He was immediately placed on the injured list. Next year’s option is valued at barely above the league minimum salary, so it’s just a matter of whether the Mets plan to devote him a roster spot all offseason. Curtiss is controllable through 2025 if the Mets keep him around.

Phillies

Segura has been the Phils’ primary second baseman for the past four seasons. He’s generally hit at a slightly above-average level, relying on excellent bat-to-ball skills to prop up an aggressive offensive approach. He’s paired that with above-average defensive ratings at the keystone. He’s lost most of this season after fracturing his finger on a bunt attempt, but he’s healthy now and performing at his typical level. Across 195 plate appearances, he owns a .284/.324/.421 line with seven home runs. Segura is a good player, but a $16MM call will probably be too much for a Philadelphia club that already has five players on the books for more than $20MM next season (and will add a sixth notable salary — more on that shortly). The market also hasn’t been particularly robust for second base-only players in recent years. Segura will be headed into his age-33 season.

This one’s a no-brainer for the Phillies to exercise. Nola is one of the sport’s top pitchers, a picture of durability and consistently above-average numbers (aside from a blip in his 2021 ERA that didn’t align with still excellent peripherals). One can argue whether Nola’s a true ace, but he’s at least a high-end #2 caliber arm. He’s given the Phils 144 2/3 innings of 3.17 ERA ball this season, striking out 27.9% of batters faced against a minuscule 3.6% walk rate. Even on a $16MM salary, he’s a bargain.

Reds

Wilson signed a complex free agent deal with the Yankees during the 2020-21 offseason. A one-year guarantee, the deal contained player and team options for 2022. Wilson and the Yankees agreed that if he triggered his $2.3MM player option for 2022, the team would get a 2023 option valued at $500K above that year’s league minimum salary. That provision carried over to the Reds when Wilson was dealt to Cincinnati at the 2021 trade deadline, and he indeed exercised the player option last winter. Next year’s league minimum is set at $720K, so Wilson’s option price will come in at $1.22MM.

It’s certainly affordable, but it still seems likely the Reds will let him go. The 34-year-old (35 next week) southpaw underwent Tommy John surgery in June, meaning he won’t return until late in the ’23 season at the earliest. He made just five appearances this season and posted a 5.29 ERA over 34 innings last year.

Brewers

Wong presents a tricky case for a Milwaukee club that typically runs slightly below-average player payrolls. He’s hitting .255/.336/.425, offense that checks in around 11 percentage points above league average according to wRC+. It’s among the better showings of his career. He doesn’t have huge power, but Wong’s an effective baserunner with plus bat-to-ball skills and good strike zone awareness. He’s a good but certainly not elite offensive player, one who’s performed about as well as Milwaukee could’ve reasonably hoped when signing him over the 2020-21 offseason.

What seems likely to determine whether the Brewers bring him back is how they evaluate his defense. A two-time Gold Glove award winner, Wong has rated as one of the sport’s best defensive second basemen for the majority of his career. Public metrics have unanimously panned his work this year, though, with Statcast’s Outs Above Average pegging him as the worst defensive second baseman in 2022. Wong’s speed has also taken a step back, and perhaps the Brewers think he’s just past his physical prime as he nears his 32nd birthday. If that’s the case, they probably buy him out, since Wong’s value has been so heavily concentrated in his glove. If they feel this year’s downturn is just a blip and expect he’ll return to his old ways on defense, then keeping him around makes sense. Like Segura, Wong could be affected by the market’s recent devaluation of second basemen. It’s also worth noting that Bob Nightengale of USA Today reported that Milwaukee was open to trade offers on Wong before this summer’s deadline. They didn’t move him, but it’s perhaps an indication the front office is leaning towards a buyout.

Boxberger has spent the past couple seasons on low-cost contracts in Milwaukee and generally performed well. He carries a 2.51 ERA through 43 innings this season, albeit with slightly worse than average strikeout and walk rates. Boxberger has a career-worst 8.4% swinging strike rate, and the front office could view his strong run prevention mark as little more than a mirage. The financial cost is modest enough they could nevertheless keep him around, particularly since manager Craig Counsell has trusted Boxberger enough to give him plenty of high-leverage opportunities (largely with good results).

Rockies

Oberg is technically controllable for another season via club option, but the Rockies will obviously decline it. He earned a three-year extension after the 2019 season on the heels of two consecutive sub-3.00 ERA campaigns, no small feat for a reliever calling Coors Field home. Unfortunately, Oberg has dealt with persistent blood clotting issues that prevented him throwing from a single major league pitch throughout the course of the contract. The 32-year-old hasn’t officially announced his retirement, but he admitted in May he’s no longer actively pursuing a return to the field. He’s taken on a role in the Colorado scouting department to stay involved with the organization.

Dodgers

  • Max Muncy, INF ($13MM option, $1.5MM buyout)

One of the game’s best hitters from 2018-21, Muncy has had a disappointing season thus far. Seemingly nagged by health issues tied to a ligament tear he suffered in his elbow late last season, he’s had a huge downturn in his offensive production. Muncy still boasts elite strike zone awareness, but his results on contact are way down. Overall, he carries a meager .180/.317/.360 line across 366 trips to the plate.

Still, given what Muncy’s shown himself capable of in the past, it seems unlikely the Dodgers let him go to save $11.5MM. This is an organization that annually runs one of the league’s highest payrolls, and they’ve shown a willingness to place one-year bets on players with upside but risk (e.g. tendering a $17MM arbitration contract to Cody Bellinger on the heels of a .165/.240/.302 season disrupted by injuries). They’ll probably do the same with Muncy and hoping he rediscovers his prior form with another offseason to rehab his elbow.

The Dodgers signed Duffy to a one-year guarantee this spring knowing he wasn’t likely to factor into the plans until midseason. He’d been shooting for a June return but has still yet to make his Dodgers debut, although he’s reportedly throwing at the team’s Arizona complex. It’s unlikely the Dodgers bring him back for $7MM given his recent health woes, but he could change those plans if he makes it back to the mound late in the season and looks like a potential impact arm, as he did at times with the Royals.

Hudson signed a one-year guarantee over the offseason and quickly emerged as a key high-leverage option for manager Dave Roberts. He dominated over 24 1/3 innings, pitching to a 2.22 ERA with an excellent 30.9% strikeout rate while averaging north of 97 MPH on his fastball. The veteran righty looked like one of the sport’s best relievers for two months, but he unfortunately blew out his knee trying to field a ground-ball. He tore his left ACL and is done for the year. The Dodgers could still roll the dice given how well he’d pitched before the injury, but that’s no longer a foregone conclusion. A $5.5MM decision isn’t onerous — particularly for L.A. — but there’s plenty of risk in Hudson’s profile given the injury and the fact that he’ll be headed into his age-36 season.

The Dodgers added the veteran Alberto on a fairly surprising big league deal. He’s been a below-average offensive player for three years running, with his solid contact skills not quite compensating for a lack of power and one of the game’s most aggressive approaches. He’s played a limited utility role, serving as a right-handed bench bat capable of splitting his time between second and third base. Next year’s option price is very affordable, but the Dodgers can probably find a hitter with a bit more punch to play the role Alberto has assumed.

Nelson underwent Tommy John surgery last August, but the Dodgers brought him back for the league minimum salary to get a cheap option on his services for next year. He’s been on the injured list for all of 2022, as expected. Whether the Dodgers keep him will depend on how he looks at the start of the offseason, but $1.1MM for a 33-year-old who posted a 1.86 ERA and punched out 37.9% of his opponents in 29 innings when last healthy is beyond reasonable.

Padres

The Padres have spent the past few years trying to get out from under the money they owe Myers. The extension to which they signed him in January 2017 never worked out, as he’d been a roughly average hitter aside from a monster showing in the shortened 2020 campaign up until this season. The 2022 season has been a disaster, as Myers owns a .233/.277/.295 showing through 159 plate appearances and has lost two months to a right knee injury. He’s healthy now but relegated to fourth outfield duty. Myers will probably find a big league opportunity somewhere this offseason, but it’ll come with a new team and with a substantial pay cut.

Giants

Longoria is nearing the end of an extension he first signed with the Rays a decade ago. His production dipped late in his stint with Tampa Bay, and Longoria slogged through a trio of mediocre seasons through his first four years in San Francisco. He’s had an offensive resurgence over the past two years, carrying a .254/.340/.468 line in 470 plate appearances going back to the start of 2021. Longoria’s still a good hitter and capable defender at the hot corner, but he’s dealt with plenty of injury concerns as he’s gotten into his late 30s. He’s gone on the injured list five times in the last two seasons, including long-term absences for a shoulder sprain and hand surgery. The hefty buyout means it’d only be an extra $8MM for San Francisco to keep him around, but it seems likely they’ll look to get younger at the hot corner. It’s possible the three-time All-Star takes the decision out of their hands entirely, as he told Susan Slusser of the San Francisco Chronicle in June that he’s not ruling out retiring after this season.

A.J. Preller, Mike Rizzo Discuss Juan Soto Trade

By | at

We’re a week removed from one of the biggest blockbusters in MLB history, the deal that sent Juan Soto and Josh Bell from the Nationals to the Padres for five young players and first baseman Luke Voit. Jeff Passan of ESPN takes a long look into the process that eventually led to the deal in a piece that’s well worth a read in full.

A Soto trade seemed unfathomable around a month before the deadline, with Washington general manager Mike Rizzo flatly stating the club wouldn’t deal him. That was before Soto passed on a 15-year, $440MM extension offer that apparently represented the Nationals final offer. At that point, Rizzo and his staff reversed course and turned their attention to the trade market. Passan writes the Nationals identified the Padres, Dodgers, Yankees, Cardinals, Mariners, Rays, Rangers and Blue Jays as a preliminary list of teams with the kind of young talent to pull off a deal.

According to Passan, the Nats had whittled that down to a trio of the Cardinals, Dodgers and Padres by the final week of July. With St. Louis reportedly reluctant to include Dylan Carlson in a package that also included a number of top prospects, Los Angeles and San Diego became the final two. Passan relays that San Diego and Washington higher-ups really gathered momentum late into the evening of August 1, the night before the trade deadline. A late entrant to discussions was the inclusion of Bell, one of the top rental bats available, to convince the Friars to part with high-upside 18-year-old pitcher Jarlin Susana. By the middle of the night on August 1-2, Passan reports, the parties agreed to the package of young talent that’d go back to Washington pending review of medical records the next morning. (Passan adds the humorous anecdote that San Diego president of baseball operations A.J. Preller then continued working deep into the night on additional trade possibilities before falling asleep in the middle of a conversation with a member of his scouting staff).

While the initial iteration of the deal included Eric Hosmer going to Washington, the first baseman exercised his limited no-trade protection to block the deal. San Diego pivoted and traded Hosmer to the Red Sox, and Passan writes that San Diego and Washington had each previously agreed that one of Voit or Wil Myers could take Hosmer’s place in the event he refused to waive his no-trade clause.

“We did as well as we could do,” Rizzo opined to Passan. “You lost a Hall of Famer at 23, but I think we expedited our reboot. When you’re looking at the alternative, the same narrative would’ve been out there this winter. If you don’t trade him now, what are you doing in the offseason? I give the Padres’ ownership credit. And I give A.J. credit because he’s not afraid to make a trade like this. And I give our ownership credit.”

Preller went into detail about his team’s involvement in the Soto discussions during an appearance this afternoon on The Show, a podcast from the New York Post with Jon Heyman and Joel Sherman. The San Diego baseball operations leader confirmed the Nationals identified his system as one of a handful that could support a blockbuster of this magnitude early in the process.

“We could tell we were going to be one of the final teams if we wanted to participate,” Preller told the Post. “You never know if you’re going to be the team. It’s like anything else, there’s going to be two or three teams that all have really strong packages. … There was just a lot of debate and discussion for us over the next few weeks about the right thing to do, the right players to give up.”

Once the sides were nearing agreement on the prospect return, the onus fell on San Diego to push the deal across the finish line, Preller explains. “At the end, you have to decide. Do you want to do this or not? That’s kind of the gut-check at the end, when the Nats put it on you: ’this five or six-player package gets it done.’ That’s when you come back into the room with your small group of people and (owner) Peter Seidler. It’s on the table if we want to do this. And if we don’t do it, ultimately we have to live with the fact that he may go elsewhere. … At the end of the day, you have to make that decision.”

Obviously, Preller and his group decided to pull the trigger, although he indicated the club wasn’t narrowly focused on a Soto deal. Preller confirmed to the Post that San Diego was involved in discussions with the Angels about Shohei Ohtani. He said there was some but not entire overlap in the young players of interest to both Washington and Anaheim but indicated the Angels were ultimately unwilling to part with Ohtani. Heyman reported last week that Angels owner Arte Moreno wouldn’t sign off on an Ohtani trade while Mike Trout is on the injured list.

Padres fans and/or anyone interested in additional details about San Diego’s trade talks will want to check out Preller’s interview with Heyman and Sherman in full. Preller also discussed the necessity of balancing a roster with star talent and depth, the acquisition of All-Star reliever Josh Hader from the Brewers, plans for rehabbing star Fernando Tatis Jr., and his team’s struggles against the Dodgers among other topics.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top